Logo

American Heart Association

  20
  0


Final ID: MP510

Reducing Carbohydrate Quantity Lowers 10-Year Predicted Risk of Cardiovascular Disease Using the PREVENT Equation: An Ancillary Study of the OMNICARB Trial

Abstract Body (Do not enter title and authors here): Background
Cardiovascular disease (CVD) remains a leading cause of death in the United States. While evidence suggests that lowering carbohydrate quantity may improve CVD risk factors and the effects of lowering carbohydrate quality [glycemic index (GI)] are mixed, their effects on predicted CVD risk remain unexplored. The American Heart Association's Predicting Risk of CVD EVENTs (PREVENT) equations offer a modern approach to CVD risk prediction. However, their application in dietary interventions targeting macronutrients is yet to be explored.
Hypothesis
Evaluate the impact of dietary carbohydrate quantity and GI on 10-year predicted CVD risk using PREVENT. We hypothesized that a low-carbohydrate, low-GI diet would reduce 10-year predicted CVD risk.
Methods
OmniCarb (NCT00608049), a 4-period randomized crossover feeding study, examined the effects of dietary GI on CVD risk factors. Overweight/obese adults without CVD were randomized to 1 of 8 diet sequences, receiving 4 isocaloric, healthful DASH-type diets (cg, cG, Cg, and CG; see Figure 1 for definitions) for 5 weeks each, with 2-week washouts. Predicted 10-year CVD risk was estimated using the base PREVENT model at baseline and after each diet period. Linear mixed-effects models assessed within-person differences in predicted risk across diets. Primary outcomes were absolute and relative differences in predicted CVD risk from baseline.
Results
Among 163 participants (mean [SD] age 52 [11] years; 52% female; 51% Black/African American, 56% obese, 64% never smokers) who completed at least 2 diet periods, median (IQR) baseline predicted risk was 3.8% (1.7%-6.0%); mean (SD) was 4.6% (3.9%). All intervention diets showed modest reductions in absolute predicted risk from baseline (Table 2). Relative reductions compared to baseline were greatest for cG and cg (Figure 1). Compared to cg, CG was associated with significantly higher predicted CVD risk (p = 0.002), while differences for cG (p = 0.493) and Cg (p = 0.092) were not significant. Compared to low-carbohydrate diets, high-carbohydrate diets were associated with a higher predicted risk (p < 0.001), whereas high-GI diets had no significant difference in risk compared to the low-GI diets (p = 0.598).
Conclusion
Reducing carbohydrate quantity, regardless of GI, led to the greatest reductions in 10-year predicted CVD risk, suggesting that carbohydrate content may be a more effective dietary target than GI for lowering cardiovascular risk in at-risk adults.
  • Ngige, Azuka  ( Johns Hopkins School of Medicine , Baltimore , Maryland , United States )
  • Miller, Hailey  ( Johns Hopkins University , Baltimore , Maryland , United States )
  • Juraschek, Stephen  ( BIDMC-Harvard Medical School , Boston , Massachusetts , United States )
  • Michos, Erin  ( Johns Hopkins Medicine , Clarksville , Maryland , United States )
  • Miller, Edgar  ( JOHNS HOPKINS MEDICAL INSTITUTIONS , Baltimore , Maryland , United States )
  • Author Disclosures:
    Azuka Ngige: DO NOT have relevant financial relationships | Hailey Miller: DO NOT have relevant financial relationships | Stephen Juraschek: DO NOT have relevant financial relationships | Erin Michos: DO have relevant financial relationships ; Consultant:Arrowhead:Active (exists now) ; Consultant:Zoll:Past (completed) ; Consultant:Pfizer:Past (completed) ; Consultant:Novartis:Past (completed) ; Consultant:Esperion:Past (completed) ; Consultant:Amgen:Past (completed) ; Consultant:Novartis:Past (completed) ; Consultant:Edwards Lifescience:Active (exists now) ; Consultant:Eli Lilly:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:New Amsterdam:Active (exists now) ; Consultant:Merck:Active (exists now) ; Consultant:Boehringer Ingelheim:Active (exists now) ; Consultant:Bayer:Active (exists now) ; Consultant:Ionis:Active (exists now) | Edgar Miller: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Dietary Intervention Trials and More

Saturday, 11/08/2025 , 09:15AM - 10:30AM

Moderated Digital Poster Session

More abstracts on this topic:
Advanced maternal age and association with major adverse cardiovascular events from NHANES from 1999 to 2018

Mehta Adhya, Honigberg Michael, Kennedy Jamie, Spitz Jared, Sharma Garima, Agboola Olayinka, Satti Danish Iltaf, Harrington Colleen, Scott Nandita, Sarma Amy, Saad Antonio, Sullivan Scott, Epps Kelly

Associations of Dietary Zinc Intake with Cardiovascular Disease and Mortality: Results from the Prospective Urban and Rural Epidemiology (PURE-China) Study

Li Xiaocong, Cai Qiujing, Huang Yilin, Biyan Biyan, Li Wei

More abstracts from these authors:
Impact of Internet Use on Knowledge of Clinical Trials: An Analysis Using the Health Information National Trends Survey (HINTS) Dataset

Hussain Zaib, Michos Erin, Miller Hailey, Dennison Himmelfarb Cheryl, Sheikhattari Payam, Barsha Rifath Ara Alam, Plante Timothy

Effects of Dietary Patterns and Sodium Intake on Blood Pressure Variability: Results from the DASH and DASH-Sodium Trials

Zou Siyu, Gao Sunan, Juraschek Stephen, Miller Edgar, Matsushita Kunihiro, Appel Lawrence

You have to be authorized to contact abstract author. Please, Login
Not Available